Skip to content

GeneDx Holdings

US · WGS #2702 by market cap Listed 1970
45.46 -3.78 -7.68%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 48.00 -2.52%
After-hours 46.35 +1.96%
Overnight 49.45 +0.43%
104.9545.4645.462026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on WGS?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bearish
  • Recent price momentum is -55.5% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 22.0% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days E → E

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall C-

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability C

How much profit the business keeps from each dollar of sales and capital.

Gross margin 69.7% Better than 83%
Operating margin -3.1% Better than 18%
Net margin -4.9% Better than 19%
Return on equity -7.6% Better than 22%
Return on invested capital -5.4% Better than 21%
Momentum D

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -47.8% Better than 6%
6-month return -3.9% Better than 49%
12-month return (ex latest month) -61.7% Better than 1%
Distance below 52-week high 73.4% Better than 5%
Financial Health C

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 2.5x Better than 66%
Debt to assets 21.6% Better than 53%
Interest coverage -185.5x Better than 4%
Analyst View A

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 100.0% Better than 77%
Upside to average target 84.3% Better than 80%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -13.19%
1M -33.87%
3M -44.93%
6M +1.63%
YTD -65.05%
1Y -66.10%
3Y +3,170.50%
5Y -81.08%

Key statistics

Price & volume

Prev close
49.24
Open
47.95
Day range
45.16 - 49.10
Avg price
46.30
Volume
912.64K
Turnover
42.25M
Amplitude
8.00%
52-week range
32.21 - 170.87

Valuation

P/E
-62.27
P/E (TTM)
-12.09
P/B
5.57
EPS
-0.73
Net profit
-21.88M
Net assets
244.70M

Share structure

Market cap
1.36B
Float cap
854.34M
Shares out
29.97M
Float shares
18.79M

Dividend & listing

Dividend (TTM)
0.00
Listing date
1970-01-01
52-week range 10% of range
32.21 170.87

73.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+1.43M net over the window

Short interest

Shares short
6.55M
As of
2026-10-30

Frequently asked questions

What is the current stock price of GeneDx Holdings (WGS)?

GeneDx Holdings last traded at 45.46. This page shows a periodic quote snapshot. Check the displayed quote time.

What is GeneDx Holdings's market cap?

About 1.36B.

What is the P/E ratio of GeneDx Holdings?

The trailing twelve-month P/E is -12.09, below its own 5-year average of 135.96 — toward the bottom of its historical range (29.27% percentile). See the Valuation tab for the full history.

Does GeneDx Holdings pay a dividend?

GeneDx Holdings does not currently pay a regular dividend.

Is GeneDx Holdings a buy according to analysts?

The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 83.80, which implies 84.3% upside from the current price. This is not investment advice.

What is GeneDx Holdings's StockVane Quant Rating?

The StockVane Momentum strategy currently rates GeneDx Holdings a E (Strong Sell). Below its 200-day average and near the bottom of the universe on momentum. Not investment advice.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

GeneDx Holdings discussion 0 comments

Add a comment